Annexon Inc (ANNX)
7.255
+0.16
(+2.33%)
USD |
NASDAQ |
Nov 05, 16:00
7.255
0.00 (0.00%)
After-Hours: 18:40
Annexon Total Liabilities (Quarterly): 45.01M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 45.01M |
| March 31, 2024 | 41.66M |
| December 31, 2023 | 47.12M |
| September 30, 2023 | 46.98M |
| June 30, 2023 | 48.29M |
| March 31, 2023 | 53.92M |
| December 31, 2022 | 53.90M |
| September 30, 2022 | 52.12M |
| June 30, 2022 | 52.66M |
| March 31, 2022 | 49.96M |
| Date | Value |
|---|---|
| December 31, 2021 | 55.13M |
| September 30, 2021 | 45.68M |
| June 30, 2021 | 36.45M |
| March 31, 2021 | 11.64M |
| December 31, 2020 | 11.67M |
| September 30, 2020 | 10.14M |
| June 30, 2020 | 13.91M |
| March 31, 2020 | 7.673M |
| December 31, 2019 | 6.368M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.368M
Minimum
Dec 2019
55.13M
Maximum
Dec 2021
36.33M
Average
45.68M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Arbutus Biopharma Corp | 37.59M |
| CEL-SCI Corp | 15.60M |
| AIM ImmunoTech Inc | 9.613M |
| IGC Pharma Inc | 2.714M |
| NovaBay Pharmaceuticals Inc | 4.542M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 406.08M |
| Shareholders Equity (Quarterly) | 361.08M |